
Kamada’s COVID Antibody Drug Small Trial, a World 1st, gets Flying Start at Hadassah in Jerusalem
The world’s first clinical trial for a coronavirus drug made from antibodies got off to a promising start at the Hadassah hospital in Jerusalem, with

Will Nanox be the Next Israeli Hit on Nasdaq?
NANO-X IMAGING LTD , an innovative medical imaging technology company, has secured over $110M in crossover equity investments from global investors since December 2019. Funds

EDAS Instant Respiratory Diagnosis wins Israel Innovation Authority COVID-19 Grant
EDAS Healthcare is a patented decision support software, enabling immediate prediction of an infectious disease, upon the first patient encounter with a physician. Based on

Future Meat wins Calcalist’s FoodTech innovation startup contest
Future Meat Technologies Ltd. was crowned Wednesday as the winner of Calcalist’s startup contest, in partnership with Tnuva, aimed at finding the next great FoodTech

FDA OKs KAHR Medical IND Application for DSP107, anti-CD47 Candidate for Solid Tumors Treatment
KAHR Medical, a cancer immunotherapy company developing novel bi-functional fusion proteins, announced today that the U.S. Food and Drug Administration has cleared its investigational new

Betalin’s Micro-Pancreas to ‘Cure’ Diabetes Ready for UK Trials
Jerusalem based Betalin Therapeutics will be submitting a request to Britain’s regulatory agency in August for human clinical trials in the UK, for their Endocrine

NOBIO COVID-19 Personal Protection Coatings Awarded Israel Innovation Authority Grant
Nobio was recently awarded a $205,000 grant from the Israel Innovation Authority to rapidly develop personal protection and surface coatings with long acting, universal protection

Yissum Spinouts Raise Record $79 million in H1 2020 Despite Coronavirus
(July 28, 2020– Jerusalem) Startups from The Hebrew University of Jerusalem raised $79 million in the first half of 2020, Yissum, the technology transfer company

New Israeli Trial on Possible Pomegranate Oil Prevents Age Related Brain Decline
Jerusalem based Granalix is to be teaming up with the Rambam Medical Center’s Memory Clinic on a new clinical trial to test the impact of